Related Experiment Video
Updated: Aug 6, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell interstitial pneumonia associated with nitrofurantoin
Charles William Hargett1, Thomas A Sporn, Victor L Roggli
1Division of Pulmonary, Allergy, and Critical Care, Duke University Medical Center, Box 3221, Durham, NC 27710, USA.
Nitrofurantoin can cause giant cell interstitial pneumonia (GIP). Diagnosis involves histopathology and bronchoalveolar lavage fluid analysis, showing multinucleated giant cells and altered T lymphocyte levels. Early treatment is key for a positive outcome.
Area of Science:
- Pulmonary Medicine
- Toxicology
- Pathology
Background:
- Nitrofurantoin is a common antibiotic used for urinary tract infections.
- Drug-induced lung injury is a recognized adverse effect of various medications.
- Giant cell interstitial pneumonia (GIP) is a rare but serious lung condition.
Observation:
- A case of GIP developed in a patient with a history of nitrofurantoin exposure.
- The patient presented with respiratory symptoms suggestive of interstitial lung disease.
Findings:
- Histopathological examination confirmed the diagnosis of GIP.
- Bronchoalveolar lavage fluid (BALF) analysis revealed characteristic findings: bizarre multinucleated giant cells (MGC), elevated T lymphocytes, and a low T lymphocyte helper/suppressor ratio.
- These BALF findings can support the diagnosis of GIP in the context of nitrofurantoin use.
Implications:
- This case highlights GIP as a rare but potential manifestation of nitrofurantoin toxicity.
- Early recognition and discontinuation of nitrofurantoin are crucial.
- Prompt therapeutic intervention may lead to a favorable clinical outcome for patients with nitrofurantoin-induced GIP.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Pyelonephritis I: Introduction
Cryptococcal Meningitis
Acute Pyelonephritis II: Diagnostic Studies and Management
Inhibitors of Bacterial DNA Synthesis
